Bioporto Stock Net Income

BIOPOR Stock  DKK 1.75  0.05  2.78%   
BioPorto fundamentals help investors to digest information that contributes to BioPorto's financial success or failures. It also enables traders to predict the movement of BioPorto Stock. The fundamental analysis module provides a way to measure BioPorto's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioPorto stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

BioPorto Company Net Income Analysis

BioPorto's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current BioPorto Net Income

    
  (57.11 M)  
Most of BioPorto's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioPorto is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, BioPorto reported net income of (57.11 Million). This is 116.73% lower than that of the Biotechnology sector and 132.99% lower than that of the Health Care industry. The net income for all Denmark stocks is 110.0% higher than that of the company.

BioPorto Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioPorto's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioPorto could also be used in its relative valuation, which is a method of valuing BioPorto by comparing valuation metrics of similar companies.
BioPorto is currently under evaluation in net income category among its peers.

BioPorto Fundamentals

About BioPorto Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BioPorto's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioPorto using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioPorto based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with BioPorto

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioPorto position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioPorto will appreciate offsetting losses from the drop in the long position's value.

Moving together with BioPorto Stock

  0.66CONFRZ Conferize ASPairCorr
The ability to find closely correlated positions to BioPorto could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioPorto when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioPorto - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioPorto to buy it.
The correlation of BioPorto is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioPorto moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioPorto moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioPorto can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in BioPorto Stock

BioPorto financial ratios help investors to determine whether BioPorto Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioPorto with respect to the benefits of owning BioPorto security.